Loading...
Derniers dépôts
-
C. Valenza, D. Trapani, François-Clément Bidard, J. Gligorov, J. Cortés, et al.. Elacestrant in ESR1-mutant, endocrine-responsive metastatic breast cancer: should health authorities consider post hoc data to inform priority access?. ESMO Open, 2024, 9 (9), ⟨10.1016/j.esmoop.2024.103701⟩. ⟨hal-04724647⟩
-
Charlotte Guyader, Jocelyn CÉRALINE, Eléonore Gravier, Aurélie Morin, Sandrine Michel, et al.. Risk of Hormone Escape in a Human Prostate Cancer Model Depends on Therapy Modalities and Can Be Reduced by Tyrosine Kinase Inhibitors. PLoS ONE, 2012, 7 (8), pp.e42252. ⟨10.1371/journal.pone.0042252⟩. ⟨hal-04791585⟩